Experimental study demonstrates enhanced photothermal conversion in aged Cu/CuO nanostructures, indicating their potential as low-cost photothermal therapy agents.
Copper-based nanostructures offer cost-effective alternatives to noble metal photothermal agents due to their strong near-infrared absorption and high thermal conductivity. In this work, Cu/CuO nanostructures were synthesized via an eco-friendly DC arc discharge in water without chemical precursors or surfactants. Optical emission spectroscopy identified excited copper- and oxygen-containing species, while Wien’s displacement law applied to the continuum-emission maxima yielded approximate effective temperatures above 8300 K, indicating the highly energetic conditions associated with nanoparticle formation. The as-synthesized colloids were aged in water and characterized at 1, 3, 7, 15, and 30 days to explore structural and optical evolution. XRD analysis with RIR-based semi-quantitative phase analysis indicated a gradual phase transformation from Cu to Cu 2 O and ultimately CuO, accompanied by an increase in the estimated CuO content from approximately 21% to 88%, while the transient Cu 2 O phase became undetectable after 7 days. FE-SEM observations further revealed the formation of anisotropic CuO nanorods during prolonged aging. XPS analysis of the representative 1-day and 7-day samples further confirmed the surface oxidation process, showing an increase in the surface Cu(II) fraction from 85% to 96% and in the lattice-oxygen contribution from 26% to 46%. UV-visible spectra indicated a redshift and bandgap reduction from 2.19 to 2.04 eV. Under 808 nm laser irradiation, the sample aged for 7 days achieved the highest photothermal conversion efficiency of 55%, associated with a favorable balance between Cu/CuO phase composition, optical absorption, morphology, and energy dissipation pathways. MTT assay results showed approximately 85% viability of L929 fibroblast cells at a concentration of 10 μg mL −1 , suggesting preliminary cytocompatibility under the tested conditions. This study highlights DC arc discharge in liquid as a clean and scalable approach for producing Cu/CuO nanostructures with promising photothermal performance and preliminary cytocompatibility, warranting further biological and photothermal treatment investigations to evaluate their potential applicability in photothermal therapy.
No takes yet. Share an insight, caveat, or question.
Nezhadfard et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: